Acquired von willebrand syndrome
MONDO:0020460Acquired von Willebrand syndrome (AVWS) is a bleeding disorder marked by the same biological anomalies as those seen in hereditary von Willebrand disease (VWD) but which occurs in association with another underlying pathology, generally in elderly patients without any personal or family history of bleeding anomalies.
Also known as: acquired von Willebrand disease, acquired von Willebrand disease (hereditary or acquired), acquired von willebrand disease, Willebrand disease, acquired
15 clinical trials for this condition and its sub-types, 3 tagged with Acquired von willebrand syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a clotting factor stop bleeding in ECMO patients?
Disease control Recruiting nowThis early-stage trial tests a single dose of a lab-made clotting protein (recombinant von Willebrand factor) in 12 adult patients on ECMO who have major bleeding. The goal is to see if the drug is safe and how it behaves in the body. If successful, it may lead to a new way to co…
Phase 1 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Scientists investigate blood vessel cells to unlock secrets of bleeding disorder
Knowledge-focused Recruiting nowThis observational study aims to understand how endothelial colony-forming cells (ECFCs) behave in people with von Willebrand disease (VWD) and acquired von Willebrand syndrome (AVWS) compared to healthy individuals. Researchers will collect blood samples from 48 participants to …
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC